Renaissance Technologies - HOMOLOGY MEDICINES INC ownership

HOMOLOGY MEDICINES INC's ticker is FIXX and the CUSIP is 438083107. A total of 58 filers reported holding HOMOLOGY MEDICINES INC in Q2 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.0%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of HOMOLOGY MEDICINES INC
ValueSharesWeighting
Q3 2023$211
-20.4%
180,000
-39.8%
0.00%
Q2 2023$265
-16.7%
299,100
-3.3%
0.00%
Q1 2023$318
-24.3%
309,217
-7.2%
0.00%
-100.0%
Q4 2022$420
-99.9%
333,153
-12.1%
0.00%0.0%
Q3 2022$610,000
+24.5%
379,100
+52.4%
0.00%0.0%
Q2 2022$490,000
-31.1%
248,800
+6.3%
0.00%0.0%
Q1 2022$711,000
+33.9%
234,000
+60.3%
0.00%0.0%
Q4 2021$531,000
-61.2%
145,993
+61.9%
0.00%0.0%
Q2 2020$1,370,000
+63.9%
90,200
+67.7%
0.00%0.0%
Q1 2020$836,00053,7860.00%
Other shareholders
HOMOLOGY MEDICINES INC shareholders Q2 2023
NameSharesValueWeighting ↓
5AM Venture Management, LLC 4,535,919$51,211,00017.25%
Vida Ventures Advisors, LLC 770,845$8,703,0001.79%
AAF Wealth Management, LLC 59,790$675,0000.61%
Vivo Capital, LLC 853,143$9,632,0000.43%
Bellevue Group AG 1,737,122$19,612,0000.22%
PREMIER ASSET MANAGEMENT LLC 77,108$871,0000.18%
Temasek Holdings (Private) Ltd 3,220,293$36,357,0000.16%
American Investment Services, Inc. 36,955$417,0000.13%
Virtus ETF Advisers LLC 24,646$278,0000.12%
FIRST MIDWEST BANK TRUST DIVISION 65,983$745,0000.11%
View complete list of HOMOLOGY MEDICINES INC shareholders